Inovio Pharmaceuticals(INO) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Inovio Pharmaceuticals Inc. Stock Slips 9.8%, Underperforms Competitors
Dow JonesFeb 24 16:33 ET
Inovio Pharmaceuticals Inc. Stock Advances 12.1%, Outperforms Competitors
Dow JonesFeb 12 16:33 ET
Inovio Respiratory DNA Drug Candidate Shows Promise in Early Trial
Seeking AlphaFeb 12 08:31 ET
Express News | INOVIO Announces Phase 1/2 Trial Results Of INO-3107 For Recurrent Respiratory Papillomatosis With 81% Of Patients Requiring Fewer Surgeries; Plans BLA Submission In Mid-2025 For FDA Accelerated Approval, Aiming To Achieve First US DNA Medicine Approval
BenzingaFeb 12 08:04 ET
Express News | Inovio Pharmaceuticals Inc - Phase 1/2 Study Results of Ino-3107 Published in Nature Communications
ReutersFeb 12 08:01 ET
Express News | Immune Response Data for Ino-3107 to Be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
ReutersFeb 10 08:05 ET

Comments

Lnova

Feb 22 15:34

Phase 1/2 Data to be Presented Feb 23-26

$Inovio Pharmaceuticals (INO.US)$
“Phase 1/2 data due to be presented at AACR-IO on February 23-26, 2025. BLA submission due in mid-2025. New immunology on Phase 1/2 data shows INO-3107 induced an expansion of new clonal T cells in blood that were not detectable prior to treatment, noted November 13, 2024.”
｡ﾟ* ҉* ੈ‧₊ ｡ﾟnot financial advice

1

Teddy123

Feb 12 07:21

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications

$Inovio Pharmaceuticals (INO.US)$
Breakthrough RRP Treatment Slashes Surgery Need: 28% of Patients Now Surgery-Free in Nature Communications Study

1

Trytosaveabit

Feb 12 07:09

Update

$Inovio Pharmaceuticals (INO.US)$ Benzinga· 4 mins ago
INOVIO Announces Phase 1/2 Trial Results Of INO-3107 For Recurrent Respiratory Papillomatosis With 81% Of Patients Requiring Fewer Surgeries; Plans BLA Submission In Mid-2025 For FDA Accelerated Approval, Aiming To Achieve First US DNA Medicine Approval

1

Jaguar8

Feb 10 18:48

🟤Watchlist, FEBRUARY 11,2025, Tuesday. NFA - DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, ...

78

10

5

Jaguar8

Feb 10 17:17

13G filed 9.2%

$Inovio Pharmaceuticals (INO.US)$

2

INO Inovio Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Trending Stocks